<html>

<head>

<title>EBG Document</title>



</head>

<body>
<p align=left><font size="2"><!-- *************************************************************************** -->
  <!-- MARKER PAGE="sheet: 1; page: 1" --></font></p>
<p align=right><font size="3"><b><font size="2">As filed with the Securities and
  Exchange Commission on February 3, 2004<br>
  Registration No. 333-____</font></b></font></p>
<table width=100%>
  <tr>
    <td>
      <hr align=LEFT width=100% size=4 noshade>
      <hr align=LEFT width=100% size=1 noshade>
</td>
  </tr>
</table>
<p><font size="1">&nbsp;</font></p>
<p align=center><font size="3"><b><font size="2">SECURITIES AND EXCHANGE COMMISSION<br>
  WASHINGTON, D.C. 20549</font></b></font> </p>
<table width=100%>
  <tr>
    <td>
      <hr size=1 noshade align=CENTER width=150>
    </td>
  </tr>
</table>
<p align=center><font size="3"><b><font size="4">FORM S-8<br>
  </font><font size="2">REGISTRATION STATEMENT<br>
  UNDER <br>
  THE SECURITIES ACT OF 1933</font></b></font><br>
</p>
<table width=100%>
  <tr>
    <td>
      <hr size=1 noshade align=CENTER width=150>
    </td>
  </tr>
</table>
<p align=center><font size="3"><b><font size="5">BRADLEY PHARMACEUTICALS, INC.<br>
  </font></b><i><font size="1">(Exact name of Registrant as specified in its charter</font><font size="2">)<br>
  </font></i></font></p>
<table width=100%>
  <tr>
    <td>
      <hr size=1 noshade align=CENTER width=150>
    </td>
  </tr>
</table>
<br>
<table border=0 cellspacing=0 cellpadding=0 width="100%">
  <tr>
    <td colspan=2 valign=top>
      <p align=center><font size="3"><b><font size="2">Delaware</font></b></font></p>
    </td>
    <td colspan=2 valign=top>
      <p align=center><font size="3"><b><font size="2">&nbsp;</font></b></font></p>
    </td>
    <td valign=top width=41%>
      <p align=center><font size="3"><b><font size="2">22-2581418</font></b></font></p>
    </td>
  </tr>
  <tr>
    <td colspan=2 valign=top>
      <p align=center><font size="3"><i><font size="1">(State or other jurisdiction
        of<br>
        incorporation or organization)</font></i></font></p>
    </td>
    <td colspan=2 valign=top>
      <p align=center><font size="3"><i><font size="1">&nbsp;</font></i></font></p>
    </td>
    <td valign=top width=41%>
      <p align=center><font size="3"><i><font size="1">(I.R.S. Employer<br>
        Identification No.)</font></i></font></p>
    </td>
  </tr>
  <tr>
    <td width=21%></td>
    <td width=21%></td>
    <td width=3%></td>
    <td width=14%></td>
    <td width=41%></td>
  </tr>
</table>
<p align=center><font size="3"><b><font size="2">383 Route 46 West<br>
  Fairfield, New Jersey 07004<br>
  (973) 882-1505<br>
  </font></b><i><font size="1">(Address, including zip code, and telephone number,
  including area code, of Registrant&#146;s principal executive offices)<br>
  </font></i></font></p>
<table width=100%>
  <tr>
    <td>
      <hr size=1 noshade align=CENTER width=150>
    </td>
  </tr>
</table>
<p align=center><font size="3"><b><font size="2">BRADLEY PHARMACEUTICALS, INC.
  401(K) SAVINGS PLAN<br>
  </font></b><i><font size="1">(Full title of the Plan)<br>
  </font></i></font></p>
<table width=100%>
  <tr>
    <td>
      <hr size=1 noshade align=CENTER width=150>
    </td>
  </tr>
</table>
<p align=center><font size="3"><b><font size="2">Daniel Glassman<br>
  President, Chief Executive Officer and Chairman of the Board<br>
  Bradley Pharmaceuticals, Inc.<br>
  383 Route 46 West<br>
  Fairfield, New Jersey 07004<br>
  (973) 882-1505<br>
  </font></b><i><font size="1">(Name, address, including zip code, and telephone
  number, including area code, of agent for service)<br>
  </font></i></font></p>
<table width=100%>
  <tr>
    <td>
      <hr size=1 noshade align=CENTER width=150>
    </td>
  </tr>
</table>
<p align=center><font size="3"><i><font size="2">Copy to:<br>
  </font></i><b><font size="2">Theodore L. Polin, Esq.<br>
  Epstein Becker &amp; Green, P.C.<br>
  50 Park Avenue<br>
  New York, New York 10017<br>
  (212) 351-4500<br>
  </font></b></font></p>
<table width=100%>
  <tr>
    <td>
      <hr size=1 noshade align=CENTER width=150>
    </td>
  </tr>
</table>
<p align=center><font size="3"><b><font size="2">CALCULATION OF REGISTRATION FEE</font></b></font></p>
<table border=0 cellspacing=0 cellpadding=0 width="100%">
  <tr valign="bottom">
    <td colspan="5">
      <hr noshade size="2">
    </td>
  </tr>
  <tr valign="bottom">
    <td>
      <p align=center><font size="3"><b><font size="1">Title of Securities<br>
        Being Registered</font></b></font></p>
    </td>
    <td>
      <p align=center><font size="3"><b><font size="1">Amount Being<br>
        Registered</font></b></font></p>
    </td>
    <td>
      <p align=center><font size="3"><b><font size="1">Proposed Maximum<br>
        Offering Price<br>
        Per Share (1)</font></b></font></p>
    </td>
    <td>
      <p align=center><font size="3"><b><font size="1">Proposed Maximum<br>
        Aggregate<br>
        Offering Price(1)</font></b></font></p>
    </td>
    <td>
      <p align=center><font size="3"><b><font size="1">Amount of <br>
        Registration Fee</font></b></font></p>
    </td>
  </tr>
  <tr>
    <td valign=top align="center">
      <p><font size="1">Common Stock, $.01 par value (2)</font></p>
    </td>
    <td valign=top>
      <p align=center><font size="1">500,000</font></p>
    </td>
    <td valign=top>
      <p align=center><font size="3"><b><font size="1">$21.29</font></b></font></p>
    </td>
    <td valign=top>
      <p align=center><font size="1"><b>$10,645,000</b></font></p>
    </td>
    <td valign=top>
      <p align=center><font size="3"><b><font size="1">$1,349</font></b></font></p>
    </td>
  </tr>
  <tr>
    <td valign=top align="center" colspan="5">
      <hr noshade size="2">
    </td>
  </tr>
</table>
<ol>
  <li><font size="2"> Estimated solely for purposes of calculating the registration
    fee pursuant to Rule 457(h)(1) of the Securities Act of 1933, on the basis
    of <b>$</b>21.29<b> </b>per share, the average of the high and low sales prices
    of the Registrant&#146;s common stock, as reported in the New York Stock Exchange
    on February 2, 2004.</font></li>
  <li><font size="2"> Includes such additional shares as may become issuable by
    reason of stock splits, stock dividends or similar transaction. In addition,
    pursuant to Rule 416(c), this registration statement also covers an indeterminate
    number of interests to be offered or sold pursuant to the employee benefit
    plan described herein. </font><font size="3"><b><font size="2">&nbsp;</font></b></font></li>
</ol>
<table width=100%>
  <tr>
    <td>
      <hr align=LEFT width=100% size=1 noshade>
      <hr align=LEFT width=100% size=4 noshade>
</td>
  </tr>
</table>
<p>&nbsp;
<table width=100%>
  <tr>
    <td width=60 align=left><font size=1>&nbsp;</font></td>
    <td width=480 align=center>&nbsp;</td>
    <td width=60 align=right><font size="1">&nbsp;</font></td>
  </tr>
</table>
<p>&nbsp;
<hr size=5 noshade width=100% align=LEFT>
<p>&nbsp; <!-- *************************************************************************** -->
  <!-- MARKER PAGE="sheet: 2; page: 2" --> <font size="3"><br clear=all>
  </font>
<div>
  <p align=center><font size="3"><b><font size="2"> PART I<br>
    <br>
    INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS</font></b></font></p>
  <p align=left><font size="3"><b><font size="2">Item 1. Plan Information.</font></b></font></p>
  <p align=left><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
    documents containing the information specified by Part I will be sent or given
    to eligible participants as specified by Rule 428(b)(1) under the Securities
    Act. These documents and the documents incorporated by reference herein pursuant
    to Item 3 of Part II below, taken together, constitute a Section 10(a) prospectus.
    </font></p>
  <p align=left><font size="2">&nbsp;</font><font size="3"><b><font size="2">Item
    2. Registrant Information and Employee Plan Annual Information.</font></b></font></p>
  <p align=left><font size="3"><b><font size="2">&nbsp;</font></b></font><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
    will provide without charge to each person to whom a copy of a Section 10(a)
    prospectus hereunder is delivered, upon the oral or written request of such
    person, a copy of any document incorporated by reference in Item 3 of Part
    II below. Requests should be directed to Bradley Pharmaceuticals,&nbsp;Inc.,
    383 Route 46 West, Fairfield, New Jersey 07004-2402, Attn: R. Brent Lenczycki,
    Chief Financial Officer, (973)&nbsp;882-1505.</font></p>
  <p align=center><font size="2">&nbsp;</font><font size="3"><b><font size="2">PART
    II</font></b></font></p>
  <p align="center"><font size="2">&nbsp;</font><font size="3"><b><font size="2">INFORMATION
    REQUIRED IN THE REGISTRATION STATEMENT</font></b></font></p>
  <p><font size="2">&nbsp;</font><font size="3"><b><font size="2">Item 3. Incorporation
    of Documents by Reference</font></b><font size="2">.</font></font></p>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We incorporate
    by reference the following documents filed by us with the SEC: </font></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
    <tr valign="bottom">
      <td width=435>
        <p><font size="3"><b><font size="1">Our SEC filings</font></b></font>
        <hr size=1 width="100%" noshade color=gray align=center>
        </td>
      <td width=116>
        <p align=center><font size="3"><b><font size="1">&nbsp;</font></b></font></p>
      </td>
      <td width=421>
        <p align=center><font size="3"><b><font size="1">Period covered or date
          of filing</font></b></font>
        <hr size=1 width="100%" noshade color=gray align=center>
      </td>
    </tr>
    <tr>
      <td width=435 valign=top>
        <p><font size="3"><br>
          <font size="2">Annual Report on Form 10-K</font></font></p>
      </td>
      <td width=116 valign=top>
        <p><font size="2"><br>
          &nbsp;</font></p>
      </td>
      <td width=421 valign=bottom>
        <p><font size="2"><br>
          Year ended December 31, 2002.</font></p>
      </td>
    </tr>
    <tr>
      <td width=435 valign=top>
        <p><font size="2">&nbsp;</font></p>
      </td>
      <td width=116 valign=top>
        <p><font size="2">&nbsp;</font></p>
      </td>
      <td width=421 valign=bottom>
        <p><font size="2">&nbsp;</font></p>
      </td>
    </tr>
    <tr>
      <td width=435 valign=top>
        <p><font size="2"><br>
          Quarterly Reports on Form 10-Q</font></p>
      </td>
      <td width=116 valign=top>
        <p><font size="2"><br>
          &nbsp;</font></p>
      </td>
      <td width=421 valign=bottom>
        <p><font size="2"><br>
          Quarters ended March 31, 2003, June 30, 2003 and September 30, 2003.</font></p>
      </td>
    </tr>
    <tr>
      <td width=435 valign=top>
        <p><font size="2"><br>
          Current Reports on Form 8-K</font></p>
      </td>
      <td width=116 valign=top>
        <p><font size="2"><br>
          &nbsp;</font></p>
      </td>
      <td width=421 valign=bottom>
        <p><font size="2"><br>
          January 30, February 26, April 25, April 30, June 9, July 25, July 31,
          and October 31, 2003 and February 2, 2004.</font></p>
      </td>
    </tr>
    <tr>
      <td width=435 valign=bottom>
        <p><font size="2"><br>
          Proxy Statement for annual meeting (other than those portions deemed
          not filed with the SEC)</font></p>
      </td>
      <td width=116 valign=bottom>
        <p><font size="2"><br>
          &nbsp;</font></p>
      </td>
      <td width=421 valign=bottom>
        <p><font size="2"><br>
          July 9, 2003.</font></p>
      </td>
    </tr>
    <tr>
      <td width=435 valign=bottom>
        <p><font size="2"><br>
          The description of our common stock, contained in our Registration Statement
          on Form 8-A, including any amendments or reports filed for the purpose
          of updating such description</font></p>
      </td>
      <td width=116 valign=bottom>
        <p><font size="2"><br>
          &nbsp;</font></p>
      </td>
      <td width=421 valign=bottom>
        <p><font size="2"><br>
          May 5, 2003.</font></p>
      </td>
    </tr>
  </table>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition,
    all documents subsequently filed with the SEC by us pursuant to Sections 13(a),
    13(c), 14 and 15(d) of the Securities Exchange Act of 1934, prior to the filing
    of a post-effective amendment which indicates that all securities offered
    hereunder have been sold or which deregisters all securities then remaining
    unsold, shall be deemed to be incorporated by reference in this Registration
    Statement and to be a part hereof from the date of filing of such documents.
    Any statement contained in a document incorporated or deemed to be incorporated
    by reference herein shall be deemed to be modified or superseded for purposes
    hereof to the extent that a statement contained herein or in any other subsequently
    filed document which also is incorporated or deemed to be incorporated by
    reference herein modifies or supersedes such statement. Any such statement
    so modified or superseded shall not be deemed, except as so modified or superseded,
    to constitute a part of this Registration Statement. </font></p>
  <p>&nbsp; </p>
  <table width=100%>
    <tr>
      <td align=left><font size=1>&nbsp;</font></td>
      <td align=center><font size="2">1 </font></td>
      <td align=right><font size="1">&nbsp;</font></td>
    </tr>
  </table>
  <p>&nbsp;
  <hr size=5 noshade width=100% align=LEFT>
  <p>&nbsp; <!-- *************************************************************************** -->
    <!-- MARKER PAGE="sheet: 2; page: 2" -->
  <p><font size="3"><b><font size="2">Item 4. Description of Securities.</font></b></font></p>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable.</font></p>
  <p><font size="3"><b><font size="2">&nbsp;Item 5. Interests of Named Experts
    and Counsel.</font></b></font></p>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not
    applicable.</font></p>
  <p><font size="2">&nbsp;</font><font size="3"><b><font size="2">Item 6.</font></b><font size="2">
    <b>Indemnification of Directors and Officers.</b></font></font></p>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under Section&nbsp;145
    of the Delaware General Corporation Law, we have broad powers to indemnify
    our officers, directors and third parties acting on our behalf against liabilities
    they may incur in such capacities, including liabilities under the Securities
    Act. </font></p>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our by-laws
    provide for the indemnification of officers, directors, employees and agents
    to the fullest extent permitted by the Delaware General Corporation Law. </font></p>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have purchased
    for the benefit of our officers and directors and those of certain of our
    subsidiaries insurance policies whereby the insurance companies agree, among
    other things, that, in general, in the event any such officer or director
    becomes legally obligated to make a payment (including legal fees and expenses)
    in connection with an alleged wrongful act, such insurance companies will
    pay us up to $10,000,000. Wrongful act means any breach of duty, neglect,
    error, misstatement, misleading statement or other act (other than gross negligence
    or willful misconduct) done by one of our officers or directors or any subsidiary.
    </font></p>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insofar as
    indemnification for liabilities arising under the Securities Act may be permitted
    to directors, officers or persons controlling us pursuant to the foregoing
    provisions, we have been informed that in the opinion of the SEC such indemnification
    is against public policy as expressed in the Securities Act and is therefore
    unenforceable. </font></p>
  <p><font size="3"><b><font size="2">Item 7. Exemption from Registration Claimed.</font></b></font></p>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not
    applicable.</font></p>
  <p><font size="2">&nbsp;</font><font size="3"><b><font size="2">Item 8. Exhibits.</font></b></font></p>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
    form of the Bradley Pharmaceuticals, Inc. 401(k) Savings Plan (the &#147;Plan&#148;)
    and amendments thereto have been submitted to the Internal Revenue Service
    (&#147;IRS&#148;) in a timely manner and have made or will make all changes
    required by the IRS in order to qualify the Plan. </font></p>
  <p><font size="2">&nbsp;</font></p>
  <div align=center>
    <table border=0 cellspacing=0 cellpadding=0>
      <tr valign="bottom">
        <td width=147>
          <p align=center><font size="2">Exhibit<br>
            </font><font size="3"><font size="2">Number</font></font>
          <hr noshade align="center" size="1" width="50%">
        </td>
        <td width=499>
          <p align=center><font size="3"><font size="2">Description of Documents</font></font>
          <hr noshade align="center" size="1" width="32%">
        </td>
      </tr>
      <tr>
        <td width=147 valign=top>
          <p align=center><font size="2">4.1</font></p>
        </td>
        <td width=499 valign=top>
          <p><font size="2">Copy of the Bradley Pharmaceuticals, Inc. 401(k) Savings
            Plan.</font></p>
        </td>
      </tr>
      <tr>
        <td width=147 valign=top>&nbsp;</td>
        <td width=499 valign=top>&nbsp;</td>
      </tr>
      <tr>
        <td width=147 valign=top>
          <p align=center><font size="2">5.1</font></p>
        </td>
        <td width=499 valign=top>
          <p><font size="2">Opinion of Epstein Becker &amp; Green, P.C.</font></p>
        </td>
      </tr>
      <tr>
        <td width=147 valign=top>&nbsp;</td>
        <td width=499 valign=top>&nbsp;</td>
      </tr>
      <tr>
        <td width=147 valign=top>
          <p align=center><font size="2">23.1</font></p>
        </td>
        <td width=499 valign=top>
          <p><font size="2">Consent of Grant Thornton, LLP.</font></p>
        </td>
      </tr>
      <tr>
        <td width=147 valign=top>&nbsp;</td>
        <td width=499 valign=top>&nbsp;</td>
      </tr>
      <tr>
        <td width=147 valign=top>
          <p align=center><font size="2">23.2</font></p>
        </td>
        <td width=499 valign=top>
          <p><font size="2">Consent of Epstein Becker &amp; Green, P.C. (included
            in Exhibit 5.1).</font></p>
        </td>
      </tr>
      <tr>
        <td width=147 valign=top>&nbsp;</td>
        <td width=499 valign=top>&nbsp;</td>
      </tr>
      <tr>
        <td width=147 valign=top>
          <p align=center><font size="2">24.1</font></p>
        </td>
        <td width=499 valign=top>
          <p><font size="2">Power of Attorney (included on the signature page
            on page S-1).</font></p>
        </td>
      </tr>
    </table>
  </div>
  <p><font size="2">&nbsp;</font></p>
  <p><font size="2">&nbsp;</font><font size="3"><b><font size="2">Item 9. Undertakings</font></b></font></p>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)&nbsp;&nbsp;&nbsp;The
    undersigned Registrant hereby undertakes:</font></p>
  <p align=left><font size="2">&nbsp;</font></p>
  <table width=100%>
    <tr>
      <td align=left><font size=1>&nbsp;</font></td>
      <td align=center><font size="2">2 </font></td>
      <td align=right><font size="1">&nbsp;</font></td>
    </tr>
  </table>
  <p>&nbsp;
  <hr size=5 noshade width=100% align=LEFT>
  <p>&nbsp; <!-- *************************************************************************** -->
    <!-- MARKER PAGE="sheet: 2; page: 2" -->
  <p align=left><font size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;&nbsp;&nbsp;To
    file, during any period in which offers or sales are being made, a post-effective
    amendment to this Registration Statement:</font></p>
</div>
<blockquote>
  <div>
    <p><font size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;To
      include any prospectus required by Section 10(a)(3) of the Securities Act
      of 1933;</font></p>
    <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;To
      reflect in the prospectus any facts or events arising after the effective
      date of the Registration Statement (or the most recent post-effective amendment
      thereof) which, individually or in the aggregate, represent a fundamental
      change in the information set forth in the Registration Statement. Notwithstanding
      the foregoing, any increase or decrease in volume of securities offered
      (if the total dollar value of securities offered would not exceed that which
      was registered) and any deviation from the low or high end of the estimated
      maximum offering range may be reflected in the form of prospectus filed
      with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes
      in volume and price represent no more than 20% change in the maximum aggregate
      offering price set forth in the &#147;Calculation of Registration Fee&#148;
      table in the effective Registration Statement;</font></p>
  </div>
  <div><font size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;To
    include any material information with respect to the plan of distribution
    not previously disclosed in the Registration Statement or any material change
    to such information in the Registration Statement;</font></div>
</blockquote>
<div>
  <p align=left><font size="2">Provided, however, that paragraphs (A)(1)(i) and
    (A)(1)(ii) of this Section do not apply if the Registration Statement is on
    Form S-3, Form S-8 or Form F-3, and the information required to be included
    in a post-effective amendment by those paragraphs is contained in periodic
    reports filed with or furnished to the Commission by the Registrant pursuant
    to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that
    are incorporated by reference in the Registration Statement;</font></p>
  <p align=left><font size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;&nbsp;&nbsp;that,
    for the purpose of determining any liability under the Act, each such post-effective
    amendment shall be deemed to be a new Registration Statement relating to the
    securities offered therein, and the offering of such securities at that time
    shall be deemed to be the initial bona fide offering thereof; and </font></p>
  <p align=left><font size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;&nbsp;&nbsp;to
    remove from registration by means of a post-effective amendment any of the
    securities being registered which remain unsold at the termination of the
    offering.</font></p>
  <p align=left><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)&nbsp;&nbsp;&nbsp;The
    undersigned Registrant hereby undertakes that, for purposes of determining
    any liability under the Act, each filing of the Registrant&#146;s annual report
    pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable,
    each filing of an employee benefit plan&#146;s annual report pursuant to Section
    15(d) of the Exchange Act) that is incorporated by reference in this Registration
    Statement shall be deemed to be a new Registration Statement relating to the
    securities offered therein, and the offering of such securities at that time
    shall be deemed to be the initial bona fide offering thereof. </font></p>
  <p align=left><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C)&nbsp;&nbsp;&nbsp;Insofar
    as indemnification for liabilities arising under the Act may be permitted
    to directors, officers and controlling persons of the Registrant pursuant
    to the provisions described in Item 6 above, or otherwise, the Registrant
    has been advised that in the opinion of the Commission such indemnification
    is against public policy as expressed in the Act and is, therefore, unenforceable.
    In the event that a claim for indemnification against such liabilities (other
    than the payment by the Registrant of expenses incurred or paid by a director,
    officer or controlling person of the Registrant in the successful defense
    of any action, suit or proceeding) is asserted by such director, officer or
    controlling person in connection with the securities being registered, the
    Registrant will, unless in the opinion of its counsel the matter has been
    settled by controlling precedent, submit to a court of appropriate jurisdiction
    the question whether such indemnification by it is against public policy as
    expressed in the Act and will be governed by the final adjudication of such
    issue.</font></p>
  <p><font size="2">&nbsp;</font> </p>
  <table width=100%>
    <tr>
      <td align=left><font size=1>&nbsp;</font></td>
      <td align=center><font size="2">3 </font></td>
      <td align=right><font size="1">&nbsp;</font></td>
    </tr>
  </table>
  <p>&nbsp;
  <hr size=5 noshade width=100% align=LEFT>
  <p>&nbsp; <!-- *************************************************************************** -->
    <!-- MARKER PAGE="sheet: 2; page: 2" --> <font face="Times New Roman" size="3"></font>
  <p><font size="2">&nbsp;</font><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
    to the requirements of the Securities Act of 1933, the Registrant certifies
    that it has reasonable grounds to believe that it meets all of the requirements
    for filing on Form S-8 and has duly caused this Registration Statement to
    be signed on its behalf by the undersigned, thereunto duly authorized, in
    Fairfield, New Jersey, on the 31st<b> </b>day of January, 2004.</font></p>
</div>
<div>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
    <tr>
      <td width=319 valign=top>
        <p><font size="2">&nbsp;</font></p>
      </td>
      <td width=319 valign=top>
        <p><font size="2">BRADLEY PHARMACEUTICALS, INC.</font></p>
      </td>
    </tr>
    <tr>
      <td width=319 valign=top>
        <p><font size="2">&nbsp;</font></p>
      </td>
      <td width=319 valign=top>
        <p>&nbsp;</p>
      </td>
    </tr>
    <tr>
      <td width=319 valign=top>
        <p><font size="2">&nbsp;</font></p>
      </td>
      <td width=319 valign=top>
        <p align=left><font size="2">By: <U>/s/ Daniel Glassman &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><br>
           Daniel Glassman,<br>
           Chairman of the Board, President <br>
           and Chief Executive Officer (Principal <br>
           Executive Officer)</font></p>
      </td>
    </tr>
  </table>
  <p align="center"><font size="2"><b>&nbsp;</b></font><b><font size="2">POWER
    OF ATTORNEY</font></b></p>
  <p align=left><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;KNOW
    ALL PERSONS BY THESE PRESENTS, that each individual whose signature appears
    below constitutes and appoints R. Brent Lenczycki and Daniel Glassman, and
    each of them, his or her true and lawful attorneys-in-fact and agents, with
    full power of substitution, for him or her and in his or her name, place and
    stead, in any and all capacities, to sign any and all amendments (including
    post-effective amendments) to this Registration Statement, and to file the
    same, with all exhibits thereto and all documents in connection therewith,
    with the Securities and Exchange Commission, granting unto said attorneys-in-fact
    and agents full power and authority to do and perform each and every act and
    thing requisite and necessary to be done in and about the premises, as fully
    to all intents and purposes as he or she might or could do in person, hereby
    ratifying and confirming all that said attorneys-in-fact and agents, or his
    or their substitute or substitutes, may lawfully do or cause to be done by
    virtue hereof.</font></p>
  <p align=left><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
    to the requirements of the Securities Act of 1933, this Registration Statement
    has been signed by the following persons in the capacities and on the dates
    indicated:</font></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
    <tr>
      <td width=213 valign=top>
        <p align=left><font size="2"><b>Signature</b></font></p>
      </td>
      <td width=213 valign=top>
        <p align=left><font size="2"><b>Title</b></font></p>
      </td>
      <td width=213 valign=top>
        <p align=left><font size="2"><b>Date</b></font></p>
      </td>
    </tr>
    <tr>
      <td width=213 valign=top>
        <p align=left>&nbsp;</p>
      </td>
      <td width=213 valign=top>
        <p align=left>&nbsp;</p>
      </td>
      <td width=213 valign=top>
        <p align=left>&nbsp;</p>
      </td>
    </tr>
    <tr>
      <td width=213 valign=top>
        <p align=left><font size="2"><u>/s/ Daniel Glassman
          </u><br>
          Daniel Glassman</font></p>
      </td>
      <td width=213 valign=top>
        <p align=left><font size="2">Chairman of the Board,<br>
          President and Chief<br>
          Executive Officer (Principal<br>
          Executive Officer)</font></p>
      </td>
      <td width=213 valign=top>
        <p align=left><font size="2">January 31, 2004</font></p>
      </td>
    </tr>
    <tr>
      <td width=213 valign=top>&nbsp;</td>
      <td width=213 valign=top>&nbsp;</td>
      <td width=213 valign=top>&nbsp;</td>
    </tr>
    <tr>
      <td width=213 valign=top>
        <p align=left><font size="2"><u>/s/ R. Brent Lenczycki
          </u><br>
          R. Brent Lenczycki, CPA</font></p>
      </td>
      <td width=213 valign=top>
        <p align=left><font size="2">Vice President and Chief<br>
          Financial Officer (Principal<br>
          Financial and Accounting Officer)</font></p>
      </td>
      <td width=213 valign=top>
        <p align=left><font size="2">January 31, 2004</font></p>
      </td>
    </tr>
    <tr>
      <td width=213 valign=top>&nbsp;</td>
      <td width=213 valign=top>&nbsp;</td>
      <td width=213 valign=top>&nbsp;</td>
    </tr>
    <tr>
      <td width=213 valign=top>
        <p align=left><font size="2"><u>/s/ Michael Bernstein
          </u><br>
          Michael Bernstein, CPA</font></p>
      </td>
      <td width=213 valign=top>
        <p align=left><font size="2">Director</font></p>
      </td>
      <td width=213 valign=top>
        <p align=left><font size="2">January 31, 2004</font></p>
      </td>
    </tr>
    <tr>
      <td width=213 valign=top>&nbsp;</td>
      <td width=213 valign=top>&nbsp;</td>
      <td width=213 valign=top>&nbsp;</td>
    </tr>
    <tr>
      <td width=213 valign=top>
        <p align=left><font size="2"><u>/s/ C. Ralph Daniel, III, M.D.
          </u><br>
          C. Ralph Daniel, III, M.D.</font></p>
      </td>
      <td width=213 valign=top>
        <p align=left><font size="2">Director</font></p>
      </td>
      <td width=213 valign=top>
        <p align=left><font size="2">January 31, 2004</font></p>
      </td>
    </tr>
  </table>
  <p>&nbsp;</p>
  <table width=100%>
    <tr>
      <td align=left><font size=1>&nbsp;</font></td>
      <td align=center><font size="2">S-1</font></td>
      <td align=right><font size="1">&nbsp;</font></td>
    </tr>
  </table>
  <p>&nbsp;
  <hr size=5 noshade width=100% align=LEFT>
  <p>&nbsp; <!-- *************************************************************************** -->
    <!-- MARKER PAGE="sheet: 2; page: 2" --> <font face="Times New Roman" size="3"></font>
  <p>&nbsp;</p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
    <tr>
      <td width=213 valign=top>
        <p align=left><font size="2"><u>/s/ Andre Fedida, M.D. </u><br>
          Andre Fedida, M.D.</font></p>
      </td>
      <td width=213 valign=top>
        <p align=left><font size="2">Director</font></p>
      </td>
      <td width=213 valign=top>
        <p align=left><font size="2">January 31, 2004</font></p>
      </td>
    </tr>
    <tr>
      <td width=213 valign=top>&nbsp;</td>
      <td width=213 valign=top>&nbsp;</td>
      <td width=213 valign=top>&nbsp;</td>
    </tr>
    <tr>
      <td width=213 valign=top>
        <p align=left><font size="2"><u>/s/ Iris S. Glassman
          </u><br>
          Iris S. Glassman</font></p>
      </td>
      <td width=213 valign=top>
        <p align=left><font size="2">Treasurer and Director</font></p>
      </td>
      <td width=213 valign=top>
        <p align=left><font size="2">January 31, 2004</font></p>
      </td>
    </tr>
    <tr>
      <td width=213 valign=top>&nbsp;</td>
      <td width=213 valign=top>&nbsp;</td>
      <td width=213 valign=top>&nbsp;</td>
    </tr>
    <tr>
      <td width=213 valign=top>
        <p align=left><font size="2"><u>/s/ Steven Kriegsman
          </u><br>
          Steven Kriegsman</font></p>
      </td>
      <td width=213 valign=top>
        <p align=left><font size="2">Director</font></p>
      </td>
      <td width=213 valign=top>
        <p align=left><font size="2">January 31, 2004</font></p>
      </td>
    </tr>
    <tr>
      <td width=213 valign=top>&nbsp;</td>
      <td width=213 valign=top>&nbsp;</td>
      <td width=213 valign=top>&nbsp;</td>
    </tr>
    <tr>
      <td width=213 valign=top>
        <p align=left><font size="2"><u>/s/ Alan G. Wolin, Ph.D.
          </u><br>
          Alan G. Wolin, Ph.D.</font></p>
      </td>
      <td width=213 valign=top>
        <p align=left><font size="2">Director</font></p>
      </td>
      <td width=213 valign=top>
        <p align=left><font size="2">January 31, 2004</font></p>
      </td>
    </tr>
    <tr>
      <td width=213 valign=top>
        <p align=left><font size="2">&nbsp;</font></p>
      </td>
      <td width=213 valign=top>
        <p align=left>&nbsp;</p>
      </td>
      <td width=213 valign=top>
        <p align=left>&nbsp;</p>
      </td>
    </tr>
  </table>
  <br>
  <br>
  <table width=100%>
    <tr>
      <td align=left><font size=1>&nbsp;</font></td>
      <td align=center><font size="2">S-2</font></td>
      <td align=right><font size="1">&nbsp;</font></td>
    </tr>
  </table>
  <p>&nbsp;
  <hr size=5 noshade width=100% align=LEFT>
  <p>&nbsp; <!-- *************************************************************************** -->
    <!-- MARKER PAGE="sheet: 2; page: 2" --> <font face="Times New Roman" size="3"></font>
  <font size="3"> </font>
  <p><font size="3"> <font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
    to the requirements of the Securities Act of 1933, the person who administers
    the Bradley Pharmaceuticals, Inc. 401(k) Plan has duly caused this Registration
    Statement to be signed on its behalf by the undersigned, thereunto duly authorized
    in Fairfield, New Jersey, on this 31st day of January, 2004.</font></font></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
    <tr>
      <td width=319 valign=top>
        <p><font size="2">&nbsp;</font></p>
      </td>
      <td width=319 valign=top>
        <p><font size="2">BRADLEY PHARMACEUTICALS, INC. 401(k) Plan</font></p>
      </td>
    </tr>
    <tr>
      <td width=319 valign=top>
        <p><font size="2">&nbsp;</font></p>
      </td>
      <td width=319 valign=top>
        <p><font size="2">Bradley Pharmaceuticals, Inc. (Plan Administrator)</font></p>
        <p>&nbsp;</p>
      </td>
    </tr>
    <tr>
      <td width=319 valign=top>
        <p><font size="2">&nbsp;</font></p>
      </td>
      <td width=319 valign=top>
        <p align=left><font size="2">By:<u> /s/ Daniel Glassman
          </u><br>
           Daniel Glassman,<br>
           Chairman of the Board, President <br>
           and Chief Executive Officer </font></p>
      </td>
    </tr>
  </table>
  <p><font size="2">&nbsp;</font></p>
  <table width=100%>
    <tr>
      <td align=left><font size=1>&nbsp;</font></td>
      <td align=center><font size="2">S-3</font></td>
      <td align=right><font size="1">&nbsp;</font></td>
    </tr>
  </table>
  <p>&nbsp;
  <hr size=5 noshade width=100% align=LEFT>
  <p>&nbsp; <!-- *************************************************************************** -->
    <!-- MARKER PAGE="sheet: 2; page: 2" --> <font face="Times New Roman" size="3"></font>
  <p align="center"><font size="2">INDEX TO EXHIBITS</font><font size="2">&nbsp;</font></p>
</div>
<div align=center>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
    <tr valign="bottom">
      <td width=229>
        <p align=center><font size="2">Exhibit<br>
          </font><font size="3"><font size="2">Number</font></font>
        <hr noshade align="center" size="1" width="30%">
      </td>
      <td width=59>&nbsp;</td>
      <td width=412>
        <p align=center><font size="2">&nbsp;</font><font size="3"><font size="2">Description
          of Documents</font></font>
        <hr noshade align="center" size="1" width="50%">
      </td>
      <td width=272>&nbsp;</td>
    </tr>
    <tr>
      <td width=229 valign=top>
        <p align=center><font size="2">4.1</font></p>
      </td>
      <td width=59 valign=top>&nbsp;</td>
      <td width=412 valign=top>
        <p><font size="2">Copy of the Bradley Pharmaceuticals, Inc. 401(k) Savings
          Plan.</font></p>
      </td>
      <td width=272 valign=top>&nbsp;</td>
    </tr>
    <tr>
      <td width=229 valign=top>
        <p align=center><font size="2">5.1</font></p>
      </td>
      <td width=59 valign=top>&nbsp;</td>
      <td width=412 valign=top>
        <p><font size="2">Opinion of Epstein Becker &amp; Green, P.C.</font></p>
      </td>
      <td width=272 valign=top>&nbsp;</td>
    </tr>
    <tr>
      <td width=229 valign=top>
        <p align=center><font size="2">23.1</font></p>
      </td>
      <td width=59 valign=top>&nbsp;</td>
      <td width=412 valign=top>
        <p><font size="2">Consent of Grant Thornton, LLP.</font></p>
      </td>
      <td width=272 valign=top>&nbsp;</td>
    </tr>
    <tr>
      <td width=229 valign=top>
        <p align=center><font size="2">23.2</font></p>
      </td>
      <td width=59 valign=top>&nbsp;</td>
      <td width=412 valign=top>
        <p><font size="2">Consent of Epstein Becker &amp; Green, P.C. (included
          in Exhibit 5.1).</font></p>
      </td>
      <td width=272 valign=top>&nbsp;</td>
    </tr>
    <tr>
      <td width=229 valign=top>
        <p align=center><font size="2">24.1</font></p>
      </td>
      <td width=59 valign=top>&nbsp;</td>
      <td width=412 valign=top>
        <p><font size="2">Power of Attorney (included on the signature page on
          page S-1).</font></p>
      </td>
      <td width=272 valign=top>&nbsp;</td>
    </tr>
  </table>
</div>
<p><font size="2">&nbsp;</font></p>
<table width=100%>
  <tr>
    <td width=60 align=left><font size=1>&nbsp;</font></td>
    <td width=480 align=center>&nbsp;</td>
    <td width=60 align=right><font size="1">&nbsp;</font></td>
  </tr>
</table>
<p>&nbsp;
<hr size=5 noshade width=100% align=LEFT>
<p>&nbsp;
<p align=center>&nbsp;</p>



</body>

</html>
[{"type": "S-8", "sequence": "1", "filename": "e16749_s8.htm", "description": "FORM S-8", "secsgml_size_bytes": 40220}]
{"company-data": {"conformed-name": "BRADLEY PHARMACEUTICALS INC", "cik": "0000864268", "assigned-sic": "2834", "irs-number": "222581418", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-112456", "film-number": "04563613"}, "business-address": {"street1": "383 RTE 46 WEST", "city": "FAIRFIELD", "state": "NJ", "zip": "08816", "phone": "9738821505"}, "mail-address": {"street1": "383 ROUTE 46 WEST", "city": "FAIRFIELD", "state": "NJ", "zip": "08816"}}
EBG Document
As filed with the Securities and
  Exchange Commission on February 3, 2004
Registration No. 333-____
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
BRADLEY PHARMACEUTICALS, INC.
(Exact name of Registrant as specified in its charter
)
Delaware
22-2581418
(State or other jurisdiction
        of
incorporation or organization)
(I.R.S. Employer
Identification No.)
383 Route 46 West
Fairfield, New Jersey 07004
(973) 882-1505
(Address, including zip code, and telephone number,
  including area code, of Registrant's principal executive offices)
BRADLEY PHARMACEUTICALS, INC.
  401(K) SAVINGS PLAN
(Full title of the Plan)
Daniel Glassman
President, Chief Executive Officer and Chairman of the Board
Bradley Pharmaceuticals, Inc.
383 Route 46 West
Fairfield, New Jersey 07004
(973) 882-1505
(Name, address, including zip code, and telephone
  number, including area code, of agent for service)
Copy to:
Theodore L. Polin, Esq.
Epstein Becker & Green, P.C.
50 Park Avenue
New York, New York 10017
(212) 351-4500
CALCULATION OF REGISTRATION FEE
Title of Securities
Being Registered
Amount Being
Registered
Proposed Maximum
Offering Price
Per Share (1)
Proposed Maximum
Aggregate
Offering Price(1)
Amount of
Registration Fee
Common Stock, $.01 par value (2)
500,000
$21.29
$10,645,000
$1,349
Estimated solely for purposes of calculating the registration
    fee pursuant to Rule 457(h)(1) of the Securities Act of 1933, on the basis
    of
$
21.29
per share, the average of the high and low sales prices
    of the Registrant's common stock, as reported in the New York Stock Exchange
    on February 2, 2004.
Includes such additional shares as may become issuable by
    reason of stock splits, stock dividends or similar transaction. In addition,
    pursuant to Rule 416(c), this registration statement also covers an indeterminate
    number of interests to be offered or sold pursuant to the employee benefit
    plan described herein.
PART I
INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS
Item 1. Plan Information.
The
    documents containing the information specified by Part I will be sent or given
    to eligible participants as specified by Rule 428(b)(1) under the Securities
    Act. These documents and the documents incorporated by reference herein pursuant
    to Item 3 of Part II below, taken together, constitute a Section 10(a) prospectus.
Item
    2. Registrant Information and Employee Plan Annual Information.
We
    will provide without charge to each person to whom a copy of a Section 10(a)
    prospectus hereunder is delivered, upon the oral or written request of such
    person, a copy of any document incorporated by reference in Item 3 of Part
    II below. Requests should be directed to Bradley Pharmaceuticals, Inc.,
    383 Route 46 West, Fairfield, New Jersey 07004-2402, Attn: R. Brent Lenczycki,
    Chief Financial Officer, (973) 882-1505.
PART
    II
INFORMATION
    REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation
    of Documents by Reference
.
We incorporate
    by reference the following documents filed by us with the SEC:
Our SEC filings
Period covered or date
          of filing
Annual Report on Form 10-K
Year ended December 31, 2002.
Quarterly Reports on Form 10-Q
Quarters ended March 31, 2003, June 30, 2003 and September 30, 2003.
Current Reports on Form 8-K
January 30, February 26, April 25, April 30, June 9, July 25, July 31,
          and October 31, 2003 and February 2, 2004.
Proxy Statement for annual meeting (other than those portions deemed
          not filed with the SEC)
July 9, 2003.
The description of our common stock, contained in our Registration Statement
          on Form 8-A, including any amendments or reports filed for the purpose
          of updating such description
May 5, 2003.
In addition,
    all documents subsequently filed with the SEC by us pursuant to Sections 13(a),
    13(c), 14 and 15(d) of the Securities Exchange Act of 1934, prior to the filing
    of a post-effective amendment which indicates that all securities offered
    hereunder have been sold or which deregisters all securities then remaining
    unsold, shall be deemed to be incorporated by reference in this Registration
    Statement and to be a part hereof from the date of filing of such documents.
    Any statement contained in a document incorporated or deemed to be incorporated
    by reference herein shall be deemed to be modified or superseded for purposes
    hereof to the extent that a statement contained herein or in any other subsequently
    filed document which also is incorporated or deemed to be incorporated by
    reference herein modifies or supersedes such statement. Any such statement
    so modified or superseded shall not be deemed, except as so modified or superseded,
    to constitute a part of this Registration Statement.
1
Item 4. Description of Securities.
Not applicable.
Item 5. Interests of Named Experts
    and Counsel.
Not
    applicable.
Item 6.
Indemnification of Directors and Officers.
Under Section 145
    of the Delaware General Corporation Law, we have broad powers to indemnify
    our officers, directors and third parties acting on our behalf against liabilities
    they may incur in such capacities, including liabilities under the Securities
    Act.
Our by-laws
    provide for the indemnification of officers, directors, employees and agents
    to the fullest extent permitted by the Delaware General Corporation Law.
We have purchased
    for the benefit of our officers and directors and those of certain of our
    subsidiaries insurance policies whereby the insurance companies agree, among
    other things, that, in general, in the event any such officer or director
    becomes legally obligated to make a payment (including legal fees and expenses)
    in connection with an alleged wrongful act, such insurance companies will
    pay us up to $10,000,000. Wrongful act means any breach of duty, neglect,
    error, misstatement, misleading statement or other act (other than gross negligence
    or willful misconduct) done by one of our officers or directors or any subsidiary.
Insofar as
    indemnification for liabilities arising under the Securities Act may be permitted
    to directors, officers or persons controlling us pursuant to the foregoing
    provisions, we have been informed that in the opinion of the SEC such indemnification
    is against public policy as expressed in the Securities Act and is therefore
    unenforceable.
Item 7. Exemption from Registration Claimed.
Not
    applicable.
Item 8. Exhibits.
The
    form of the Bradley Pharmaceuticals, Inc. 401(k) Savings Plan (the "Plan")
    and amendments thereto have been submitted to the Internal Revenue Service
    ("IRS") in a timely manner and have made or will make all changes
    required by the IRS in order to qualify the Plan.
Exhibit
Number
Description of Documents
4.1
Copy of the Bradley Pharmaceuticals, Inc. 401(k) Savings
            Plan.
5.1
Opinion of Epstein Becker & Green, P.C.
23.1
Consent of Grant Thornton, LLP.
23.2
Consent of Epstein Becker & Green, P.C. (included
            in Exhibit 5.1).
24.1
Power of Attorney (included on the signature page
            on page S-1).
Item 9. Undertakings
(A)   The
    undersigned Registrant hereby undertakes:
2
(1)   To
    file, during any period in which offers or sales are being made, a post-effective
    amendment to this Registration Statement:
(i)   To
      include any prospectus required by Section 10(a)(3) of the Securities Act
      of 1933;
(ii)   To
      reflect in the prospectus any facts or events arising after the effective
      date of the Registration Statement (or the most recent post-effective amendment
      thereof) which, individually or in the aggregate, represent a fundamental
      change in the information set forth in the Registration Statement. Notwithstanding
      the foregoing, any increase or decrease in volume of securities offered
      (if the total dollar value of securities offered would not exceed that which
      was registered) and any deviation from the low or high end of the estimated
      maximum offering range may be reflected in the form of prospectus filed
      with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes
      in volume and price represent no more than 20% change in the maximum aggregate
      offering price set forth in the "Calculation of Registration Fee"
      table in the effective Registration Statement;
(iii)   To
    include any material information with respect to the plan of distribution
    not previously disclosed in the Registration Statement or any material change
    to such information in the Registration Statement;
Provided, however, that paragraphs (A)(1)(i) and
    (A)(1)(ii) of this Section do not apply if the Registration Statement is on
    Form S-3, Form S-8 or Form F-3, and the information required to be included
    in a post-effective amendment by those paragraphs is contained in periodic
    reports filed with or furnished to the Commission by the Registrant pursuant
    to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that
    are incorporated by reference in the Registration Statement;
(2)   that,
    for the purpose of determining any liability under the Act, each such post-effective
    amendment shall be deemed to be a new Registration Statement relating to the
    securities offered therein, and the offering of such securities at that time
    shall be deemed to be the initial bona fide offering thereof; and
(3)   to
    remove from registration by means of a post-effective amendment any of the
    securities being registered which remain unsold at the termination of the
    offering.
(B)   The
    undersigned Registrant hereby undertakes that, for purposes of determining
    any liability under the Act, each filing of the Registrant's annual report
    pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable,
    each filing of an employee benefit plan's annual report pursuant to Section
    15(d) of the Exchange Act) that is incorporated by reference in this Registration
    Statement shall be deemed to be a new Registration Statement relating to the
    securities offered therein, and the offering of such securities at that time
    shall be deemed to be the initial bona fide offering thereof.
(C)   Insofar
    as indemnification for liabilities arising under the Act may be permitted
    to directors, officers and controlling persons of the Registrant pursuant
    to the provisions described in Item 6 above, or otherwise, the Registrant
    has been advised that in the opinion of the Commission such indemnification
    is against public policy as expressed in the Act and is, therefore, unenforceable.
    In the event that a claim for indemnification against such liabilities (other
    than the payment by the Registrant of expenses incurred or paid by a director,
    officer or controlling person of the Registrant in the successful defense
    of any action, suit or proceeding) is asserted by such director, officer or
    controlling person in connection with the securities being registered, the
    Registrant will, unless in the opinion of its counsel the matter has been
    settled by controlling precedent, submit to a court of appropriate jurisdiction
    the question whether such indemnification by it is against public policy as
    expressed in the Act and will be governed by the final adjudication of such
    issue.
3
Pursuant
    to the requirements of the Securities Act of 1933, the Registrant certifies
    that it has reasonable grounds to believe that it meets all of the requirements
    for filing on Form S-8 and has duly caused this Registration Statement to
    be signed on its behalf by the undersigned, thereunto duly authorized, in
    Fairfield, New Jersey, on the 31st
day of January, 2004.
BRADLEY PHARMACEUTICALS, INC.
By:
/s/ Daniel Glassman
Daniel Glassman,
Chairman of the Board, President
and Chief Executive Officer (Principal
Executive Officer)
POWER
    OF ATTORNEY
KNOW
    ALL PERSONS BY THESE PRESENTS, that each individual whose signature appears
    below constitutes and appoints R. Brent Lenczycki and Daniel Glassman, and
    each of them, his or her true and lawful attorneys-in-fact and agents, with
    full power of substitution, for him or her and in his or her name, place and
    stead, in any and all capacities, to sign any and all amendments (including
    post-effective amendments) to this Registration Statement, and to file the
    same, with all exhibits thereto and all documents in connection therewith,
    with the Securities and Exchange Commission, granting unto said attorneys-in-fact
    and agents full power and authority to do and perform each and every act and
    thing requisite and necessary to be done in and about the premises, as fully
    to all intents and purposes as he or she might or could do in person, hereby
    ratifying and confirming all that said attorneys-in-fact and agents, or his
    or their substitute or substitutes, may lawfully do or cause to be done by
    virtue hereof.
Pursuant
    to the requirements of the Securities Act of 1933, this Registration Statement
    has been signed by the following persons in the capacities and on the dates
    indicated:
Signature
Title
Date
/s/ Daniel Glassman
Daniel Glassman
Chairman of the Board,
President and Chief
Executive Officer (Principal
Executive Officer)
January 31, 2004
/s/ R. Brent Lenczycki
R. Brent Lenczycki, CPA
Vice President and Chief
Financial Officer (Principal
Financial and Accounting Officer)
January 31, 2004
/s/ Michael Bernstein
Michael Bernstein, CPA
Director
January 31, 2004
/s/ C. Ralph Daniel, III, M.D.
C. Ralph Daniel, III, M.D.
Director
January 31, 2004
S-1
/s/ Andre Fedida, M.D.
Andre Fedida, M.D.
Director
January 31, 2004
/s/ Iris S. Glassman
Iris S. Glassman
Treasurer and Director
January 31, 2004
/s/ Steven Kriegsman
Steven Kriegsman
Director
January 31, 2004
/s/ Alan G. Wolin, Ph.D.
Alan G. Wolin, Ph.D.
Director
January 31, 2004
S-2
Pursuant
    to the requirements of the Securities Act of 1933, the person who administers
    the Bradley Pharmaceuticals, Inc. 401(k) Plan has duly caused this Registration
    Statement to be signed on its behalf by the undersigned, thereunto duly authorized
    in Fairfield, New Jersey, on this 31st day of January, 2004.
BRADLEY PHARMACEUTICALS, INC. 401(k) Plan
Bradley Pharmaceuticals, Inc. (Plan Administrator)
By:
/s/ Daniel Glassman
Daniel Glassman,
Chairman of the Board, President
and Chief Executive Officer
S-3
INDEX TO EXHIBITS
Exhibit
Number
Description
          of Documents
4.1
Copy of the Bradley Pharmaceuticals, Inc. 401(k) Savings
          Plan.
5.1
Opinion of Epstein Becker & Green, P.C.
23.1
Consent of Grant Thornton, LLP.
23.2
Consent of Epstein Becker & Green, P.C. (included
          in Exhibit 5.1).
24.1
Power of Attorney (included on the signature page on
          page S-1).